JP2015520165A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520165A5 JP2015520165A5 JP2015512903A JP2015512903A JP2015520165A5 JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5 JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- compound
- formula
- process according
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648534P | 2012-05-17 | 2012-05-17 | |
| US61/648,534 | 2012-05-17 | ||
| PCT/US2013/041687 WO2013173779A1 (en) | 2012-05-17 | 2013-05-17 | Process for making amino acid compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015520165A JP2015520165A (ja) | 2015-07-16 |
| JP2015520165A5 true JP2015520165A5 (enExample) | 2016-06-30 |
| JP6196294B2 JP6196294B2 (ja) | 2017-09-13 |
Family
ID=48483247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512903A Active JP6196294B2 (ja) | 2012-05-17 | 2013-05-17 | アミノ酸化合物を製造するためのプロセス |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9278917B2 (enExample) |
| EP (1) | EP2850054B1 (enExample) |
| JP (1) | JP6196294B2 (enExample) |
| KR (1) | KR102074535B1 (enExample) |
| CN (1) | CN104520263B (enExample) |
| AU (1) | AU2013262516B2 (enExample) |
| BR (1) | BR112014028585B1 (enExample) |
| CA (1) | CA2873658C (enExample) |
| ES (1) | ES2668477T3 (enExample) |
| HR (1) | HRP20180948T1 (enExample) |
| IL (1) | IL235630A (enExample) |
| MA (1) | MA37751B1 (enExample) |
| MX (1) | MX350443B (enExample) |
| MY (1) | MY171538A (enExample) |
| NZ (1) | NZ702939A (enExample) |
| PL (1) | PL2850054T3 (enExample) |
| RU (1) | RU2643146C2 (enExample) |
| SG (1) | SG11201407625WA (enExample) |
| SI (1) | SI2850054T1 (enExample) |
| TR (1) | TR201807444T4 (enExample) |
| WO (1) | WO2013173779A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2858989T3 (da) | 2012-05-17 | 2020-06-02 | Genentech Inc | Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil |
| KR102123131B1 (ko) | 2012-05-17 | 2020-06-15 | 제넨테크, 인크. | 하이드록실화 사이클로펜타피리미딘 화합물 및 이의 염의 제조 방법 |
| DK2861582T3 (en) | 2012-05-17 | 2016-08-22 | Array Biopharma Inc | A process for preparing hydroxylated compounds cyclopentylpyrimidin |
| JP6214636B2 (ja) | 2012-05-17 | 2017-10-18 | アレイ バイオファーマ、インコーポレイテッド | ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス |
| HRP20231100T1 (hr) | 2013-11-15 | 2023-12-22 | F. Hoffmann - La Roche Ag | Postupci za proizvodnju pirimidinilciklopentan spojeva |
| SG10201806450SA (en) | 2014-09-26 | 2018-09-27 | Hoffmann La Roche | PROCESSES FOR PREPARING (CYCLOPENTYL[d]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
| CA2178829A1 (en) | 1993-12-12 | 1995-06-15 | Yigal Cohen | A novel method to protect plants from fungal infection |
| EP0973396A4 (en) | 1997-04-07 | 2001-02-07 | Merck & Co Inc | METHOD FOR TREATING CANCER |
| US6201023B1 (en) | 1997-06-10 | 2001-03-13 | Agrogene Ltd. | Methods and compositions to protect crops against plant parasitic nematodes |
| EP0982300A3 (en) | 1998-07-29 | 2000-03-08 | Societe Civile Bioprojet | Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| CA2363169A1 (en) | 1999-03-03 | 2000-09-08 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| WO2001022963A1 (en) | 1999-09-27 | 2001-04-05 | Merck & Co., Inc. | Method of preventing osteoporosis |
| WO2004108673A2 (en) | 2003-06-09 | 2004-12-16 | Boehringer Ingelheim International Gmbh | Inhibitors of papilloma virus |
| FR2892416B1 (fr) | 2005-10-20 | 2008-06-27 | Sanofi Aventis Sa | Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique |
| US8927546B2 (en) | 2006-02-28 | 2015-01-06 | Dart Neuroscience (Cayman) Ltd. | Therapeutic piperazines |
| US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| UA95641C2 (xx) | 2006-07-06 | 2011-08-25 | Эррей Биофарма Инк. | Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы |
| US20100298289A1 (en) | 2007-10-09 | 2010-11-25 | Ucb Pharma, S.A. | Heterobicyclic compounds as histamine h4-receptor antagonists |
| EP2419404B1 (en) | 2009-04-15 | 2015-11-04 | AbbVie Inc. | Anti-viral compounds |
| AU2010310786B2 (en) | 2009-10-23 | 2014-03-27 | Eli Lilly And Company | AKT inhibitors |
| US9050334B2 (en) | 2010-07-16 | 2015-06-09 | Innov88 Llc | MIF inhibitors and their uses |
| WO2012177925A1 (en) | 2011-06-21 | 2012-12-27 | The Board Institute, Inc. | Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene |
| KR102123131B1 (ko) | 2012-05-17 | 2020-06-15 | 제넨테크, 인크. | 하이드록실화 사이클로펜타피리미딘 화합물 및 이의 염의 제조 방법 |
| JP6214636B2 (ja) | 2012-05-17 | 2017-10-18 | アレイ バイオファーマ、インコーポレイテッド | ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス |
| CA2889855A1 (en) | 2012-11-01 | 2014-05-08 | Robert S. Katz | Methods for treating fibromyalgia |
| EP2956441A4 (en) | 2013-02-18 | 2016-11-02 | Scripps Research Inst | MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL |
| US10131637B2 (en) | 2013-03-15 | 2018-11-20 | Shifa Biomedical Corporation | Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases |
-
2013
- 2013-05-17 CN CN201380037572.0A patent/CN104520263B/zh active Active
- 2013-05-17 SG SG11201407625WA patent/SG11201407625WA/en unknown
- 2013-05-17 KR KR1020147035263A patent/KR102074535B1/ko active Active
- 2013-05-17 NZ NZ702939A patent/NZ702939A/en not_active IP Right Cessation
- 2013-05-17 MY MYPI2014703417A patent/MY171538A/en unknown
- 2013-05-17 BR BR112014028585-3A patent/BR112014028585B1/pt active IP Right Grant
- 2013-05-17 RU RU2014150991A patent/RU2643146C2/ru active
- 2013-05-17 ES ES13724711.0T patent/ES2668477T3/es active Active
- 2013-05-17 TR TR2018/07444T patent/TR201807444T4/tr unknown
- 2013-05-17 MX MX2014013863A patent/MX350443B/es active IP Right Grant
- 2013-05-17 AU AU2013262516A patent/AU2013262516B2/en active Active
- 2013-05-17 HR HRP20180948TT patent/HRP20180948T1/hr unknown
- 2013-05-17 US US14/401,095 patent/US9278917B2/en active Active
- 2013-05-17 WO PCT/US2013/041687 patent/WO2013173779A1/en not_active Ceased
- 2013-05-17 SI SI201331043T patent/SI2850054T1/en unknown
- 2013-05-17 CA CA2873658A patent/CA2873658C/en active Active
- 2013-05-17 PL PL13724711T patent/PL2850054T3/pl unknown
- 2013-05-17 EP EP13724711.0A patent/EP2850054B1/en active Active
- 2013-05-17 JP JP2015512903A patent/JP6196294B2/ja active Active
- 2013-05-17 MA MA37751A patent/MA37751B1/fr unknown
-
2014
- 2014-11-11 IL IL235630A patent/IL235630A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012103850A (ru) | Би-арил-мета-пиримидиновые ингибиторы киназ | |
| PE20081609A1 (es) | Compuestos carboxamida y su uso como inhibidores de calpaina | |
| JP2013521295A5 (enExample) | ||
| JP2007269812A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| JP2018531941A5 (enExample) | ||
| JP2012507568A5 (enExample) | ||
| ME02558B (me) | Inhibitori replikacije virusa gripa | |
| JP2011513410A5 (enExample) | ||
| JP2007522220A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| ATE383360T1 (de) | 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h- pyrido(2,3-d)pyrimidinderivate und verwandte verbindungen zur behandlung von krebs | |
| JP2013032389A5 (enExample) | ||
| JP2011510079A5 (enExample) | ||
| ECSP067077A (es) | Derivados de pirrolopiridina y su uso como antagonistas de crth2 | |
| JP2009530282A5 (enExample) | ||
| JP2011227454A5 (enExample) | ||
| JP2013500304A5 (enExample) | ||
| MX377235B (es) | Proceso mejorado para preparar bifenilanilidas y bifenilanilinas cloradas. | |
| RU2012148909A (ru) | Новый синтез соединений тиазолидиндиона | |
| MX2009013730A (es) | Compuesto amina y uso farmaceutico del mismo. | |
| JP2011522839A5 (enExample) | ||
| JP2015518837A5 (enExample) | ||
| MX2007007098A (es) | Derivados de pirrol que tienen actividad antagonista del receptor crth2. | |
| RU2014150991A (ru) | Способ получения аминокислотных соединений |